EMA - ETF NOTED USFDA'S CONCLUSION THAT EFFICACY OF JYNNEOS IN PREVENTION OF MONKEYPOX CAN BE INFERRED FROM ANTIBODY RESPONSES AGAINST VACCINIA VIRUS IN CLINICAL STUDIES